Dr. Sandler on Options for Maintenance Therapy: Switch, Continuation, or a Treatment Break?
An Update on ECOG 1505: Will Avastin (Bevacizumab) Become Standard Treatment for Early Stage Lung Cancer Patients?
Small Cell Lung Cancer Clinical Trial: Is ECOG 2511 Right for You?
Do You See Advances in Treatment for Small Cell Lung Cancer in the Near Future?
ECOG 1505 Study: No Benefit of Post-Operative Avastin in Early Stage Lung Cancer Patients
What is the Role of Bevacizumab in Stage IV NSCLC?
Discover more
Search
